Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a disease with a very unfavorable prognosis. Surgical resection represents the only potentially curative treatment option, but recurrence after complete resection is almost certain. In an exploratory attempt we here aimed at identifying preoperative plasma...

Descripción completa

Detalles Bibliográficos
Autores principales: Rittmann, Marie-Claire, Hussung, Saskia, Braun, Lukas M., Klar, Rhena F. U., Biesel, Esther A., Fichtner-Feigl, Stefan, Fritsch, Ralph, Wittel, Uwe A., Ruess, Dietrich A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021576/
https://www.ncbi.nlm.nih.gov/pubmed/33820913
http://dx.doi.org/10.1038/s41598-021-86779-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021576/
https://www.ncbi.nlm.nih.gov/pubmed/33820913
http://dx.doi.org/10.1038/s41598-021-86779-x

Ejemplares similares